Showing 17,821 - 17,840 results of 104,144 for search '(( 5 ((ng decrease) OR (a decrease)) ) OR ( 50 ((nn decrease) OR (we decrease)) ))', query time: 1.73s Refine Results
  1. 17821
  2. 17822

    Case selection flow chart. by Sara Garcia-Ptacek (693846)

    Published 2023
    “…The mortality in non-COVID geriatric patients showed a similar trend, but of lower magnitude (5–10%). …”
  3. 17823
  4. 17824
  5. 17825
  6. 17826
  7. 17827
  8. 17828
  9. 17829
  10. 17830
  11. 17831
  12. 17832
  13. 17833
  14. 17834
  15. 17835

    Passenger mutations accurately classify human tumors by Marina Salvadores (6589187)

    Published 2019
    “…The advantage of passenger mutations was upheld under high rates of false negative mutation calls and with exome sequencing, even though overall accuracy decreased. We suggest whole genome sequencing is valuable for classifying tumors because it captures global patterns emanating from mutational processes, which are informative of the underlying tumor biology.…”
  16. 17836

    One and Done Epinephrine in Out-of-Hospital Cardiac Arrest? Outcomes in a Multiagency United States Study by Nicklaus P. Ashburn (9470666)

    Published 2022
    “…However, ROSC was more common post-implementation [42.3% (380/899) vs. 32.5% (257/791); OR 0.66, 95%CI 0.54–0.81]. After adjusting for covariates, the single-dose protocol was associated with similar survival to discharge rates (aOR 0.88, 95%CI 0.77–1.29), but with decreased ROSC rates (aOR 0.58, 95%CI 0.47–0.72).…”
  17. 17837
  18. 17838
  19. 17839

    Changes in the neutrophil count. by Lu Yang (30847)

    Published 2025
    “…</p><p>Methods</p><p>This is a single-center, prospective, randomized controlled study conducted from June 1, 2021, to October 31, 2022 on patients diagnosed with locally advanced NPC. …”
  20. 17840

    Changes in the platelet count. by Lu Yang (30847)

    Published 2025
    “…</p><p>Methods</p><p>This is a single-center, prospective, randomized controlled study conducted from June 1, 2021, to October 31, 2022 on patients diagnosed with locally advanced NPC. …”